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In this study, several modiﬁcations were introduced to a recently proposed human
ventricular action potential (AP) model so as to render it suitable for the study of
ventricular arrhythmias. These modiﬁcations were driven by new sets of experimental
data available from the literature and the analysis of several well-established cellular
arrhythmic risk biomarkers, namely AP duration at 90 per cent repolarization (APD90),
AP triangulation, calcium dynamics, restitution properties, APD90 adaptation to
abrupt heart rate changes, and rate dependence of intracellular sodium and calcium
concentrations. The proposed methodology represents a novel framework for the
development of cardiac cell models. Five stimulation protocols were applied to the
original model and the ventricular AP model developed here to compute the described
arrhythmic risk biomarkers. In addition, those models were tested in a one-dimensional
ﬁbre in which hyperkalaemia was simulated by increasing the extracellular potassium
concentration, [K+]o. The effective refractory period (ERP), conduction velocity (CV)
and the occurrence of APD alternans were investigated. Results show that modiﬁcations
improved model behaviour as veriﬁed by: (i) AP triangulation well within experimental
limits (the difference between APD at 50 and 90 per cent repolarization being
78.1ms); (ii) APD90 rate adaptation dynamics characterized by fast and slow time
constants within physiological ranges (10.1 and 105.9 s); and (iii) maximum S1S2
restitution slope in accordance with experimental data (SS1S2 = 1.0). In simulated tissues
under hyperkalaemic conditions, APD90 progressively shortened with the degree of
hyperkalaemia, whereas ERP increased once a threshold in [K+]o was reached ([K+]o ≈
6mM). CV decreased with [K+]o, and conduction was blocked for [K+]o > 10.4mM.
APD90 alternans were observed for [K+]o > 9.8mM. Those results adequately reproduce
experimental observations. This study demonstrated the value of basing the development
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of AP models on the computation of arrhythmic risk biomarkers, as opposed to joining
together independently derived ion channel descriptions to produce a whole-cell AP
model, with the new framework providing a better picture of the model performance
under a variety of stimulation conditions. On top of replicating experimental data at
single-cell level, the model developed here was able to predict the occurrence of APD90
alternans and areas of conduction block associated with high [K+]o in tissue, which is of
relevance for the investigation of the arrhythmogenic substrate in ischaemic hearts.
Keywords: electrophysiology; cardiac arrhythmias; human ventricular cell model;
hyperkalaemia
1. Introduction
Mathematical modelling and simulation of the heart’s electrical activity (so-called
cardiac electrophysiology) and signal processing of bioelectrical signals provide
an ideal framework to combine the information from clinical and experimental
studies with the understanding of their underlying mechanisms. Tools capable
of testing different hypotheses and predicting potential abnormalities in the
heart’s behaviour can be produced within that framework. In the relatively
near future, it is not unlikely that those tools might even be used in clinical
practice as complementary instruments to help in the prevention of cardiac
diseases and the improvement of their diagnosis and therapy. Speciﬁcally, for the
study of ventricular arrhythmias, it remains essential to have an action potential
(AP) model able to reproduce experimentally and clinically observed arrhythmic
behaviours at cell and tissue level. This would allow simulation of the electrical
activity of the heart from the cell to the body surface and a total in silico
reconstruction of the most well-known bioelectrical signal, the electrocardiogram,
to be used for investigation of the mechanisms and manifestations of ventricular
arrhythmias at different scales.
In the last few years, a number of mathematical models of electrical and ionic
homeostasis in human ventricular myocytes have been proposed. One of the most
extensively used models is the one proposed by ten Tusscher & Panﬁlov [1]
(TP06), which is an improved version of the model described by ten Tusscher
et al. [2] (TNNP04), where the calcium dynamics, the slow delayed rectiﬁer
potassium current (IKs) and the L-type calcium current (ICaL) were reformulated.
Both the TNNP04 and the TP06 models are based on experimental human
data for most of the main ionic currents. One of the major advantages of the
TP06 model against previous human ventricular models is that it accurately
reproduces restitution of the AP duration (APD90), as will be illustrated in §3 of
this paper. On the other hand, the TP06 model has the major shortcomings
of being insensitive to changes in certain ionic current densities [3] and of
inadequately representing the rate dependence of intracellular calcium levels [4],
which will also be veriﬁed in the present study. Another relevant model of human
ventricular cells was proposed by Iyer et al. [5] (IMW04). That model provides
a detailed description of calcium homeostasis and reproduces diverse aspects of
the excitation–contraction coupling (ECC). However, important limitations have
been reported for this model, including the fact that it is extremely sensitive to
variations in the sodium–potassium pump (INa,K) and inward rectiﬁer potassium
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(IK1) current densities [3] and that it produces very long APs and relatively
ﬂat restitution curves in tissues [6]. On top of that, the most relevant ionic
currents in the IMW04 model are described using Markovian chains, with the
consequent increase in complexity (more than 60 state variables), which imposes
serious restrictions on the size of the time step required for stability and increases
the overall computational time when using this model in tissue simulations [6].
Recently, a new model of human ventricular AP has been proposed by Grandi
et al. [7] (GPB). The development of that model departs from the rabbit ECC
model proposed by Shannon et al. [8], which includes the subsarcolemmal and
junctional compartments in the formulation of the currents and provides a
detailed description of calcium handling. The GPB model includes new deﬁnitions
of ionic current densities and kinetics according to recent experimental data
on human myocytes. This model is deﬁned for two types of cells, namely
endocardial and epicardial. The deﬁnitions of those two cell types differ only
in the maximal conductivity of the fast and slow components of the transient
outward potassium current (Ito). The GPB model improves the AP response to
frequency changes and offers a better performance against blockades of potassium
currents (IK1, IKs and the rapid delayed rectiﬁer potassium current IKr) with
respect to the TP06 model. The major drawback of the GPB model is that
it does not adequately reproduce S1S2 restitution properties nor APD90 rate
adaptation dynamics, as will be illustrated in this study. Those drawbacks can
be attributed to the fact that the GPB model was developed from a rabbit
ventricular model, and the characteristics of S1S2 restitution and APD90 rate
adaptation are notably different in the two species. Table 1 presents a summary
with the main differences between the three models described above, i.e. TP06,
IMW04 and GPB.
Despite the fact that the human ventricular AP models currently available
in the literature are able to reproduce certain electrophysiological properties,
they fail in representing other relevant aspects, as pointed out above. In order
to obtain a model suitable for the study of ventricular arrhythmias, in this
study a human ventricular AP model was developed that departs from the
GPB model. The methodology followed for model development was based on
the computation of well-established arrhythmic risk biomarkers and the results
of a sensitivity analysis of the modulation of those biomarkers by variations
in the main ionic currents. Using that methodology, key limitations of the
GPB model were unravelled and inadequacies in the deﬁnitions of speciﬁc
ionic current characteristics were identiﬁed. Based on those ﬁndings, gating
kinetics of the ICaL current were reformulated by introducing both fast and
slow voltage-dependent inactivation gates [1], maximal INa,K was reduced to best
match the experimental APD90 rate adaptation data and the IK1 current was
redeﬁned by accounting for recent experimental data published in the literature
[9]. The new model, developed by Carro et al. in this paper (CRLP), was
tested and compared with the original GPB model and with the widely used
TP06 model. The IMW04 model was left out of the comparison because of
the limitations pointed out above. Model comparison was based on 12 cellular
arrhythmic risk biomarkers computed using ﬁve different stimulation protocols,
as in Romero et al. [4]. Our results show that the introduced modiﬁcations
brought most biomarkers into the physiological range, and considerably improved
others with respect to the GPB and the TP06 models. In addition, the CRLP
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Table 1. Differences between human ventricular cell models. Data are obtained from Niederer et al.
[3], Romero et al. [4] and Bueno-Orovio et al. [6] and from simulations performed in this study.
TP06 IMW04 GPB
state variables 20 67 38
computation time short very long long
cell types endo, mid, epi epi endo, epi
steady-state AP
properties
physiological APD
values, very low
triangulation
physiological APD
values and
triangulation
physiological APD
values and
triangulation
steady-state calcium
levels
low diastolic and
systolic values
low diastolic and
systolic values
very low diastolic and
systolic values
APD90 adaptation to
abrupt heart rate
changes
very fast very slow rabbit characteristics
sodium and calcium
rate dependence
very sensitive to
increasing
stimulation
frequency
physiological
behaviour
physiological
behaviour
APD sensitivity to
variations in ionic
current densities
less sensitive to INa,K,
INa,Ca, IKs, IK1, ICaL,
IKr and INa
highly sensitive to
INa,K and IK1
less sensitive to IKr
and highly sensitive
to IK1
model was tested by simulating hyperkalaemic conditions in tissues. Under
those conditions, potassium starts to pour out of ischaemic myocardial cells,
causing depolarization of the myocardium at rest, slowing conduction and
decreasing excitability. Recovery of excitability is known to outlast repolarization,
a phenomenon termed post-repolarization refractoriness. Our results show that
under hyperkalaemia APD90 progressively decreased with the level of extracellular
potassium, [K+]o, whereas the effective refractory period (ERP) increased after a
threshold in the level of [K+]o was surpassed. Conduction velocity (CV) decreased
with [K+]o and conduction was blocked above [K+]o = 10.4mM. Additionally,
APD90 alternans appeared for [K+]o > 9.8mM. These results suggest that the
model is suitable to represent areas of inhomogeneities of resting potential and
dispersion in the recovery of excitability corresponding to different hyperkalaemic
levels within the tissue. Those areas of inhomogeneities could provide a setting
for unidirectional block that could become the substrate for arrhythmias in
ischaemic hearts.
2. Methods
(a)Model development
In this study, a human ventricular cell model was developed that departs from
the recently proposed GPB model. Before describing the modiﬁcations introduced
into the new model, a brief description of the GPB model is in order.
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(i)The GPB model
The GPB model describes the AP of endocardial and epicardial human
myocytes. For both cell types, the total transmembrane ionic current, Iion, is
given by
Iion = INatot + ICltot + ICatot + IKtot ,
where each of the individual currents denotes the current generated on passing
sodium, chlorine, calcium and potassium ions through the cell membrane,
respectively.
Sodium current. Following the approach of Shannon et al. [8], the sodium
current was divided into two components: (i) a subsarcolemmal component and
(ii) a junctional component, which correspond to the cell compartments where
the current is generated. Both components are formed by the same subcurrents:
INatotjunc = INajunc + INaBkjunc + 3Incxjunc + 3INa,Kjunc + ICaNajunc ,
INatotsl = INasl + INaBksl + 3Incxsl + 3INa,Ksl + ICaNasl
and INatot = INatotjunc + INatotsl ,
where INa is the fast sodium current, INaBk is the background sodium current,
Incx is the current of the sodium–calcium exchanger, INa,K is the current of the
sodium–potassium pump and ICaNa is the sodium current through the L-type
calcium channels.
Chlorine current. The chlorine current, which is not present in the TP06 model,
is described in the GPB model by
ICltot = IClCa + IClBk,
where IClCa is the calcium-activated chlorine current, and IClBk is the background
chlorine current.
Calcium current. The calcium current, as in the case of the sodium current,
has two components, junctional and subsarcolemmal:
ICatotjunc = ICajunc + ICaBkjunc + IpCajunc − 2Incxjunc ,
ICatotsl = ICasl + ICaBksl + IpCasl − 2Incxsl
and ICatot = ICatotjunc + ICatotsl ,
where ICa is the calcium current through the L-type calcium channels, ICaBk is
the background calcium current, IpCa is the sarcolemmal calcium pump current
and Incx is the current of the sodium–calcium exchanger.
Potassium current. The potassium current is deﬁned as
IKtot = Ito + IKr + IKs + IK1 − 2INa,K + ICaK + IKp,
where Ito is the transient outward potassium current (decomposed into a fast
and a slow component), IKr is the rapidly activating potassium current, IKs
is the slowly activating potassium current (decomposed into junctional and
subsarcolemmal components), IK1 is the inward rectiﬁer potassium current, INa,K
is the current of the sodium–potassium pump (decomposed into junctional and
subsarcolemmal components), ICaK is the potassium current through the L-type
calcium channels (decomposed into junctional and subsarcolemmal components)
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and IKp is the plateau potassium current. In the GPB model, differentiation
between endocardial and epicardial cells is set by assigning different contributions
to the fast and slow Ito components.
(ii)The CRLP model
Taking the GPB model as a starting point, the CRLP model was built by
reformulating two ionic currents (ICaL and IK1) and redeﬁning a number of model
parameters, including GNa (maximum INa conductance) and GNa,K (maximal
INa,K value). Those changes were motivated by the poor performance exhibited
by the GPB model on two particular aspects: (i) the shape and slope of the
S1S2 APD90 restitution curve, and (ii) the response of the APD90 to abrupt
changes in heart rate (see below). The failure of the GPB model in reproducing
experimental data on those two aspects could be attributed to an inheritance
from the Shannon rabbit ventricular model from which the GPB model was
developed. In this regard, the development of the CRLP model from the GPB
model was made by considering human data only [3]. The following paragraphs
describe the introduced modiﬁcations, as well as the data and criteria used in the
development process. A full description of the CRLP model along with a CellML
implementation of it can be found in the electronic supplementary material.
In order to maintain as much consistency as possible with the original GPB
model, the CRLP model was developed for the same type of myocardial cells as
the GPB model, namely endocardial and epicardial. Differentiation between the
two cell types was based on the deﬁnition of the Ito fast and slow components, in
the same way as previously described for the GPB model.
L-type calcium current (ICaL). In order to obtain an APD90 adaptation response
to abrupt changes in cycle length (CL) in better concordance with experimental
data, the L-type calcium current was reformulated. The voltage-dependent
inactivation gate f of the GPB model was replaced with the product of a fast, f ,
and a slow, f2, inactivation gate, as in ten Tusscher et al. [1]. The new equations
for the L-type current in the CRLP model are
ICajunc =FjuncCaL × I¯Caj × d × f × f2(1− fCaBj ),
ICasl =FslCaL × I¯Casl × d × f × f2(1− fCaBsl ),
ICaNajunc =FjuncCaL × I¯Naj × d × f × f2(1− fCaBj ),
ICaNasl =FslCaL × I¯Nasl × d × f × f2(1− fCaBsl ),
ICaK = I¯K × d × f × f2(FjuncCaL × (1− fCaBj )+ FslCaL × (1− fCaBsl )),
ICa = ICajunc + ICasl ,
ICaNa = ICaNajunc + ICaNasl
and ICaL = ICa + ICaK + ICaNa .
As indicated in Niederer et al. [3], the replacement of one current component by
another one is not a simple task. Splitting the f gate in the GPB model into two
new gates required the readjustment of the time constants tf2 associated with the
slow voltage-dependent inactivation gate f2 and the time constant td associated
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Figure 1. Characteristics of ICaL and IK1 in simulations and experiments. (a) Simulated ICaL
voltage-dependent inactivation time constants ti as a function of voltage, where i ∈ {f , f2}.
Experimental data, represented by symbols, were taken from [10–14] (blue full line, tf CRLP; green
dashed line, tf2 CRLP; red dashed line, tf GPB; ﬁlled light blue circles, inactivation; ﬁlled dark
blue squares, slow inactivation; ﬁlled green triangles, fast inactivation). (b) ICaL current density
versus voltage, with experimental data taken from [14–16] (red dashed line, GPB; green full line,
CRLP; open blue circles, [15]; open blue squares, [14]; crosses, [16]). (c) IK1 current density versus
voltage, with experimental data taken from [9] (red dashed line, GPB; green full line, CRLP;
blue dotted line, [9]). To compare simulated and experimental data under the same conditions,
[K+]i = 138mM and [K+]o = 4mM were used for the curves shown in (c), with [K+]i denoting the
intracellular potassium concentration. (Online version in colour.)
with the activation gate d in order to obtain a meaningful ICaL current–voltage
curve (splitting the f gate without readjusting the time constants would have led
to a current–voltage curve having two relative minima).
Readjustment of tf2 was based on available experimental data [10–14].
Figure 1a depicts tf and tf2 along with experimental data [10–14]. Since the
experimental data do not cover the entire voltage range, the readjustment was
performed by best ﬁtting the tail of the tf2 curve while obtaining a current–
voltage curve within the range of experimental data. The other voltage-dependent
inactivation time constant, tf , was kept as in the study of ten Tusscher et al. [1].
The equations describing f and f2 are:
fss = 11+ e(Vm+20)/7 ,
af = 1102.5 e−((Vm+27)/15)2 ,
bf = 2001+ e(13−Vm)/10 ,
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gf = 1801+ e(Vm+30)/10 + 20,
tf = af + bf + gf ,
df
dt
= fss − f
tf
,
f2ss =
0.67
1+ e(Vm+35)/7 + 0.33,
af2 = 300 e−(Vm+25)
2/170,
bf2 =
31
1+ e(25−Vm)/10 ,
gf2 =
16
1+ e(Vm+30)/10 ,
tf2 = af2 + bf2 + gf2
and
df2
dt
= f2ss − f2
tf2
,
where Vm denotes transmembrane voltage.
Readjustment of td was based on the description provided in ten Tusscher
et al. [1]:
dss = 11+ e−(Vm+5)/6 ,
ad = 1.41+ e(−35−Vm)/13 + 0.25,
bd = 1.41+ e(Vm+5)5 ,
gd = 11+ e(50−Vm)20 ,
td = adbd + gd
and
dd
dt
= dss − d
td
.
The deﬁnitions of the calcium-dependent inactivation gates, fCaBj and fCaBsl ,
were taken as in the GPB model:
dfCaBj
dt
= 1.7 Caj(1− fCaBj )− 11.9× 10−3 fCaBj
and
dfCaBsl
dt
= 1.7 Casl (1− fCaBsl )− 11.9× 10−3 fCaBsl .
Additionally, based on the results of the sensitivity of APD90 to variations
in the maximal ICaL conductivity and the actual APD90 value in the GPB model
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(see later tables), the relative permeabilities of the L-type calcium channels were
set to:
pCa = 1.9887 × 10−4 cm s−1,
pK = 5.4675× 10−8 cm s−1,
pNa = 3.0375× 10−9 cm s−1,
I¯Caj =
pCa ×Vm × Frdy× FoRT(Caj × e2Vm×FoRT − Cao)
e2Vm×FoRT − 1 ,
I¯Casl =
pCa ×Vm × Frdy× FoRT(Casl × e2Vm×FoRT − Cao)
e2Vm×FoRT − 1 ,
I¯Naj =
pNa ×Vm × Frdy× FoRT(Naj × eVm×FoRT −Nao)
eVm×FoRT − 1 ,
I¯Nasl =
pNa ×Vm × Frdy× FoRT(Nasl × eVm×FoRT −Nao)
eVm×FoRT − 1
and I¯K = pK ×Vm × Frdy× FoRT(Ki × e
Vm×FoRT −Ko)
eVm×FoRT − 1 ,
where Frdy is Faraday’s constant, FoRT is the ratio between Faraday’s constant
and the product of the gas constant and the absolute temperature, I¯ km is
the maximal current for ion k in the compartment m, and pk is the relative
permeability of ion k.
The current–voltage curve obtained with the new deﬁnition of the ICaL current
was compared with the experimental data [14–16] and with the original deﬁnition
of the GPB model. Figure 1b shows the different current–voltage curves, where
it can be observed that the new deﬁnition of ICaL is in good agreement with the
available experimental data [14–16], with the additional beneﬁt of contributing
to physiological model response in terms of S1S2 APD90 restitution and APD90
rate adaptation dynamics.
Inward rectiﬁer K current (IK1). The IK1 current was redeﬁned using recent
experimental data from human ventricular cells published in the literature [9].
The new deﬁnition for IK1 is as follows:
aK1 = 4.0941.0+ e0.1217(Vm−EK−49.934) ,
bK1 = 15.720 e
0.0674(Vm−EK−3.257) + e0.0618(Vm−EK−594.31)
1.0+ e−0.1629(Vm−EK+14.207) ,
K1ss = aK1aK1 + bK1
and IK1 = 0.5715
√ [K+]o
5.4
×K1ss(Vm − EK),
where EK is the [K+] reversal potential. Figure 1c shows the modiﬁed IK1 current
compared with the experimental data from [9] and with IK1 from the GPB model.
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Na/K pump current (INa,K). In order to improve the APD90 adaptation
response to abrupt changes in CL, maximal INa,K was reduced by 45 per cent with
respect to its value in the GPB model. That reduction was set based on the results
of the sensitivity analysis for the tslow biomarker that will be described below.
[K+]i and GNa. A more physiological value for [K+]i of 138mM was used in our
model. Considering this value for [K+]i makes the model more excitable when
compared with the original GPB model because of the increased availability
of sodium channels. Therefore, in order to obtain physiological values for the
maximal upstroke velocity, dV /dt, in tissue, the maximum conductance of the
sodium current, GNa, was reduced to 18.864mSmF−1. This modiﬁcation led to
a maximal upstroke velocity of 228mVms−1 in the simulated one-dimensional
tissue (see below), which is in good agreement with the experimental results
from [17].
(iii)Numerical methods and implementation
The cell membrane was modelled as an electrical circuit [18]. Mathematically,
the transmembrane voltage Vm was described by the following ordinary
differential equation:
Cm
dVm
dt
= −(Iion − Istim), (2.1)
where t is time, Iion is the sum of all transmembrane ionic currents, Istim is the
externally applied stimulation current and Cm is the cell capacitance per unit
surface area.
Propagation of the electrical activity in a one-dimensional ﬁbre was described
by the following parabolic reaction–diffusion equation [19]:
Cm
vVm
vt
= −(Iion − Istim)+ v
vx
(
s
vV
vx
)
, (2.2)
where s is the diffusion coefﬁcient of the tissue and x denotes the coordinate
along the ﬁbre.
Physical units in the model are as follows: time t is given in milliseconds,
transmembrane potential Vm in millivolts, current densities in picoamperes per
picofarad, and ionic concentrations in millimoles per litre.
The GPB and CRLP models were implemented in Fortran based on the original
codes provided by Eleonora Grandi. The TP06 model was also implemented in
Fortran from the original C codes available at Kirsten ten Tusscher’s web page:
www-binf.bio.uu.nl/khwjtuss. A CellML implementation of the CRLP model is
available in the electronic supplementary material.
Cells and tissues were stimulated with square transmembrane current pulses
twice the diastolic threshold in amplitude and 1ms duration. For single-cell
simulations, forward Euler integration with a time step Dt = 0.002ms was used
to integrate the system of differential equations governing the cellular electrical
behaviour. For the one-dimensional simulations, a homogeneous 4 cm long ﬁbre
composed of epicardial cells was considered. A semi-implicit operator-splitting
scheme [20] was used to solve equation (2.2) with a space discretization of
Dx = 0.1mm and a time step of Dt = 0.002ms. A value of s= 0.0013 cm2 ms−1
was used, corresponding to a maximum CV of 74 cm s−1, which is in agreement
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with experimentally reported CV values [21]. The cell capacitance was set to
Cm = 1mF cm−2. Five positions within the ﬁbre were selected for further analysis
in each simulation. Those positions were located at 1.5, 1.75, 2, 2.25 and 2.5
cm from the stimulation end of the cable. Reported APD90 and CV values were
computed as mean values over those positions. In all cases, the Rush and Larsen
integration scheme [22] was used to integrate the Hodgkin–Huxley type equations
for the gating variables of the various time-dependent currents (m, h and j for
INa; xtof , xtos , ytof and ytos for Ito; xkr for IKr; xks for IKs; and d, f and f2 for ICaL).
In order to test the sensitivity of the numerical solution to the time and space
discretization indicated above, simulations were performed using a time increment
of 0.5ms and a spatial discretization of 0.05mm. Differences of less than 0.2 per
cent for the steady-state biomarkers computed in isolated cells were obtained
when compared with the default time and space steps used in this study. In
tissues, CV and APD90 varied by less than 1.5 and 0.02 per cent, respectively.
Also, other stimulus durations (from 1 to 3ms) and amplitudes (from 1.5 to 2
times the diastolic threshold) were tested and conﬁrmed to provide very similar
results (differences in terms of APD90, maximal upstroke velocity as well as CV
in tissues were in all cases below 0.2%, 1.6% and 0.8%, respectively).
(b) Arrhythmic risk biomarkers and stimulation protocols
Arrhythmic risk biomarkers were used in this study to guide the modiﬁcations
applied to the GPB model to produce the CRLP model. Speciﬁcally, biomarkers
related to S1S2 restitution and APD90 rate adaptation dynamics were identiﬁed
as not being adequately reproduced by the GPB model, and appropriate
modiﬁcations (described in the previous section) were performed. Those and other
biomarkers were also used to evaluate the performance of the CRLP model and
compare it with that of the TP06 and GPB models.
In the following subsections, the cellular arrhythmic risk biomarkers used in
this study are presented, and the protocols used to compute them are described.
(i) Selected biomarkers
— APD90: APD has been traditionally considered as the main preclinical
marker of drug cardiotoxicity. APD prolongation has been linked to long
Q–T syndrome and increased risk of developing torsades de pointes [23,24].
APD90 is used in this study to denote AP duration at 90 per cent
repolarization (ﬁgure 2a).
— Triangulation: this biomarker quantiﬁes the shape of the ﬁnal part of the
AP, and is calculated as the difference between APD at 50 and 90 per
cent repolarization (ﬁgure 2a). Low triangulation values indicate square
APs, while high values indicate triangular APs. Triangulation has been
proposed as a marker of pro-arrhythmia [23], with long APD90 values
without triangular APs considered as anti-arrhythmic, and triangular APs
considered as pro-arrhythmic in general.
— Systolic and diastolic intracellular calcium ([Ca2+]i) levels: calcium
transient properties evaluated at different frequencies have been reported
as risk markers [25,26]. In this study, diastolic (level at rest) and systolic
(level at peak) calcium transient levels were evaluated at 0.5 and 1Hz,
respectively (ﬁgure 2b).
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Figure 2. Graphical description (using simulation results) of the biomarkers of arrhythmic risk
used in this study: (a) steady-state AP properties (APD90, AP triangulation); (b) steady-state
[Ca2+]i properties (systolic ‘sys’ and diastolic ‘dia’ values); (c) APD90 adaptation to abrupt
changes in CL (from 1000 to 600ms and again to 1000ms), characterized by time constants
tfast and tslow; (d) APDR curve computed using the S1S2 protocol; (e) APDR curve computed
using the dynamic protocol; and (f ) normalized rate dependence of systolic concentrations, with
normalization performed with respect to the lowest tested frequency, i.e. 0.25Hz. For a better
understanding of the protocols used to compute the biomarkers shown in (a–f ), see the description
provided in §2b(ii). (Online version in colour.)
— Time constants of APD90 adaptation to abrupt changes in CL: adaptation
of ventricular repolarization duration to abrupt changes in CL has been
proposed as an arrhythmic risk marker [27]. In this study, the dynamics of
APD90 adaptation to abrupt changes in CL were ﬁtted by two exponentials
with associated time constants tfast and tslow (ﬁgure 2c), following the
methodology proposed in Pueyo et al. [28].
— Maximum slope of APD90 restitution curves: the maximum slope of the
APD90 restitution (APDR) curve has been suggested as an arrhythmic
risk marker [29,30]. The APDR curve describes the relationship between
APD90 and the diastolic interval (DI) (ﬁgure 2d–e). In this study, APDR
was evaluated using the S1S2 and the dynamic protocols (see §2b(ii)).
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— Rate dependence of Na+ and Ca2+ concentrations: the importance of
intracellular sodium, [Na+]i, and intracellular calcium, [Ca2+]i, dynamics
in arrhythmogenesis has been extensively reported [31,32]. In this study,
systolic [Na+]i and [Ca2+]i levels were evaluated for increasing stimulation
frequencies (ﬁgure 2f ).
(ii) Stimulation protocols
Five stimulation protocols were applied to evaluate the risk biomarkers
presented in §2b(i).
— Steady-state protocol : a train of 3000 stimulation pulses was delivered
and steady state was guaranteed to be reached. Simulations were carried
out using two different CL values (1000 and 2000ms). The evaluated
biomarkers were: APD90 at 1Hz, triangulation at 1Hz, systolic [Ca2+]i
at 0.5 and 1Hz and diastolic [Ca2+]i at 0.5 and 1Hz (ﬁgure 2a,b).
— Abrupt changes in CL protocol : the cell was stimulated with a CL of
1000ms for 8min, then with a CL of 600ms for an additional 8 min and
ﬁnally with a CL of 1000ms for 8min (ﬁgure 2c). The APD90 dynamics
after the ﬁrst abrupt CL change were ﬁtted by two exponentials with
time constants tfast and tslow. APD90 adaptation dynamics after the second
abrupt CL change provided very similar results to those obtained for the
ﬁrst CL change, in accordance with earlier studies [4,28], and are not
reported.
— S1S2 protocol : a train of 10 basic stimulations (S1) were applied to the cell
or tissue at a CL of 1000ms followed by an extra stimulus (S2) delivered
at coupling intervals (CI) ranging from 1000 to 250ms in variable steps
(100ms for DI> 300ms, 5ms for 150<DI< 300ms and 1ms for 5<DI<
150ms). The S1S2 restitution curve was obtained by plotting the APD90
corresponding to the extra stimulus versus the previous DI for each of the
tested CI values (ﬁgure 2d).
— Dynamic protocol : in this protocol, 100 stimulations were applied at a
given CL, with the CL ranging from 1000 to 50ms. The APDR curve was
obtained by plotting the steady-state APD90 (corresponding to the 100th
stimulus of each CL) versus the corresponding steady-state DI (ﬁgure 2e).
— Rate-dependence protocol : the systolic values of both [Na+]i and [Ca2+]i
concentrations were measured at different frequencies (0.25, 0.5, 1, 1.5, 2,
2.5 and 3Hz) and normalized to the level of the minimum frequency. For
each frequency, the cell was stimulated during 10min to reach steady state
and [Na+]i and [Ca2+]i were measured at the end of the 10min period.
The maximum normalized concentration value was computed and used as
a biomarker (ﬁgure 2f ).
(c) Conducted simulations
(i) Sensitivity analysis
A sensitivity analysis was performed using the original GPB model following
the methodology described in Romero et al. [4]. The aim was to elucidate
how different ionic current properties modulate the investigated arrhythmic risk
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biomarkers. In the sensitivity analysis, each parameter was varied one at a time by
±30%. Also, variations of ±15% were considered to assess biomarkers’ response to
different degrees of variation. These percentages are in agreement with variability
levels reported in experiments performed in human ventricular tissue [9,14,33–37].
The following parameters were considered in the sensitivity analysis.
— GCaL: maximal conductance of the L-type calcium current (ICaL).
— tf : time constant of the fast voltage-dependent inactivation gate (f ) of the
ICaL current.
— tf 2: time constant of the slow voltage-dependent inactivation gate (f2) of
the ICaL current.
— GKr: maximal conductance of the rapidly activating potassium current
(IKr).
— GKs: maximal conductance of the slowly activating potassium current
(IKs).
— txs: time constant of the activation gate (xKs) of the IKs current.
— GK1: maximal conductance of the inward rectiﬁer potassium current (IK1).
— GNa,K: maximal value of the sodium–potassium pump current (INa,K).
— Gncx: maximal value of the sodium–calcium exchanger current (Incx).
— Gto: maximal conductance of the transient outward potassium current
(Ito).
For each biomarker c and parameter p, the percentage of change (Dc,p,a) and
sensitivity (Sc,p,a) was calculated as follows [4]:
Dc,p,a = Cp,a − CcontrolCcontrol × 100
and
Sc,p,a = Dc,p,a −Dc,p,−a2a × 100,
where Cp,a is the value of biomarker c when the parameter p is varied
by the percentage a, and Ccontrol is the value of biomarker c under control
conditions. As shown above, sensitivity (Sc,p,a) was calculated as the ratio of the
difference between the percentage of change (Dc,p,a −Dc,p,−a) and the interval of
change (2a). In this study, we used this deﬁnition particularized for a = 30%:
Sc,p,30 = Dc,p,+30 −Dc,p,−300.6 .
Larger percentages of variation (±60% and ±90%) in model parameters were
additionally investigated to conﬁrm the validity of the sensitivity analysis results
under more severe ionic alterations.
(ii)Potassium current blocks
The following cases of total and partial potassium current blocks were
simulated.
— IKs: to simulate the effect of 1mM of HMR-1556, IKs was completely
blocked.
— IKr: to simulate the effect of 50 nM of dofetilide, IKr was completely blocked.
— IK1: to simulate the effect of 10mM of BaCl2, IK1 was reduced by 50
per cent.
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Figure 3. APs computed with the TP06, GPB and CRLP models for (a–c) isolated cells and
(d–f ) one-dimensional ﬁbre tissue at CL= 1000ms: (a) TP06 cellular AP; (b) GPB cellular AP;
(c) CRLP cellular AP; (d) TP06 tissue AP; (e) GPB tissue AP; and (f ) CRLP tissue AP. (Online
version in colour.)
(iii)Restitution in tissue
CV and APD90 restitution were additionally investigated in tissue by applying
the S1S2 protocol described in §2b(ii), with the only difference that the extra
stimulus (S2) was in this case decreased in steps of 5ms.
(iv)Hyperkalaemic conditions
Hyperkalaemic conditions were simulated by increasing [K+]o from 4 to 15mM.
For each [K+]o value, the diastolic threshold used to compute the stimulus
amplitude was determined as follows: The model was ﬁrst stabilized until the
product of the gates h × j reached 99 per cent of the steady-state value hss × jss.
Stimulation current pulses of variable amplitude were applied at one end of the
cable, and the diastolic threshold was deﬁned as the minimum amplitude required
for an AP to propagate along the ﬁbre. With the model initialized at 1Hz steady
state, ERP was determined by stimulating the tissue with a train of 10 basic
stimulations (S1) delivered at a CL of 1000ms, followed by an extra stimulus
(S2) delivered at different times taken in 1ms steps. Steady-state CV and APD90
were measured after the last S1 stimulus.
3. Results
(a) Results for control conditions
(i)APs in cell and tissue
Figure 3 presents APs computed from the TP06, GPB and CRLP models for an
isolated epicardial cell and for an epicardial cell coupled in tissue. In all cases, APs
correspond to steady-state pacing at CL= 1000ms. As can be appreciated from
the ﬁgure, the AP duration is of the same order in the three models. However, the
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Table 2. Results of the sensitivity analysis applied to the GPB model. The blue scale indicates
relative sensitivity for each biomarker. White colour indicates maximum relative sensitivity and
dark blue colour indicates that property and parameter are independent. Percentages in the
white boxes indicate the absolute sensitivity of the property. A minus sign in a box indicates
that biomarker and model parameter vary inversely. ‘sys’ stands for systolic and ‘dia’ stands for
diastolic. (Online version in colour.)
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AP shape is notably more triangular for the GPB and the CRLP models when
compared with the TP06 model, which presents a ﬂatter plateau phase. Also,
phase 1 of the AP substantially differs from one model to another, particularly
when comparing TP06 with the other two models. Those differences are to some
extent attenuated when comparing APs measured in tissue. It is also clear from
the ﬁgure that maximal upstroke velocity is considerably reduced for tissue APs
when compared with cell APs. While for the GPB and CRLP models, maximum
voltage occurs at the upstroke peak in both cell and tissue, for the TP06 model,
the maximum voltage at the plateau is even larger than at the upstroke peak in
tissue AP, as previously noted by Bueno-Orovio et al. [6] for the TNNP04 model
from which the TP06 model was developed.
(ii) Sensitivity analysis
The results of the sensitivity analysis applied to the epicardial version of
the GPB model are presented in table 2. This table shows the dependence of
a large number of arrhythmic risk biomarkers on the ICaL current. Not only
biomarkers related to systolic and diastolic [Ca2+]i levels, but also APD90 and
S1S2 restitution slope are mostly sensitive to variations in ICaL. Also, table 2
shows the importance of the IK1 current for AP triangulation. INa,K is determinant
for [Na+]i rate dependence as well as for the time constant of the slow phase of
APD90 rate adaptation. Note that APD90 rate adaptation dynamics computed
from the GPB model do not present a characteristic biphasic behaviour as
reported in experimental studies [38], but adaptation is completed in only one
slow phase. For that reason, the biomarker tfast described in §2b(i) is not shown
in table 2. Finally, Incx is relevant for [Ca2+]i rate dependence. Table 2 together
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Table 3. Biomarkers of arrhythmic risk for the TP06, GPB and CRLP human models. Normal font
indicates within physiological range. Bold font indicates out of physiological range but better than
previous models. Italic font indicates out of physiological range. Experimental data are from earlier
studies [14,17,25,38–43].
biomarker TP06 GPB CRLP physiological
APD90 (ms) 301.2 285.0 305.6 271–366
triangulation (ms) 28.4 51.5 78 44–112
sys [Ca2+]i 1 Hz (mM) 0.886 0.383 0.602 1.59–2.01
sys [Ca2+]i 0.5Hz (mM) 0.199 0.345 0.523 0.71–1.68
dia [Ca2+]i 1 HZ (mM) 0.104 0.089 0.097 0.20–0.33
dia [Ca2+]i 0.5Hz (mM) 0.068 0.085 0.091 0.14–0.32
SmaxS1S2 (—) 1.3 0.2 1.0 0.79–4.25
SmaxDYN (—) 1.0 1.1 0.9 —
tfast (s) 13.3 — 10.2 —
tslow (s) 124.8 56.3 105.6 70–110
max. sys. [Ca2+]i (%) 1157 178 147 130–170
max. sys. [Na+]i (%) 217 132 134 145
with the validation analysis presented in the following subsection were the road
map to carry out the various model improvements proposed in this work, which
were described in §2a.
To conﬁrm that the results of the sensitivity analysis presented in table 2 were
not dependent on the limit (30%) considered for parameter variations, simulations
were performed considering larger percentages of variations of up to 90 per cent.
Despite the fact that, in some cases, a highly nonlinear modulation of speciﬁc
risk biomarkers by certain ionic mechanisms was observed (e.g. triangulation
modulation by GK1, systolic [Ca2+]i modulation by GCaL or tslow modulation by
GNa,K), the results corroborated the mechanisms identiﬁed as determinant for the
investigated risk biomarkers in the sensitivity analysis.
(iii)Arrhythmic risk biomarkers
Table 3 shows the values of the computed biomarkers for the epicardial versions
of the three models analysed in this study (TP06, GPB and CRLP). Simulation
results were compared against a variety of experimental data taken from earlier
studies [14,17,25,38–43].
Results indicate that the GPB model performs better than the TP06 model
with respect to the following biomarkers: AP triangulation, steady-state systolic
and diastolic [Ca2+]i levels at 0.5Hz, and rate dependence of [Na+]i and
[Ca2+]i. Those biomarkers are illustrated for the three analysed models in
ﬁgure 4a–g. However, according to other analysed biomarkers, the GPB model
renders worse performance than the TP06 model, as is the case for the S1S2
restitution curve and the APD90 adaptation to abrupt changes in CL. Regarding
the APD90 adaptation, two phases of APD90 rate adaptation were experimentally
reported in the study of Franz et al. [38]: a ﬁrst phase with a short time constant
and a second phase with a longer time constant. As described in §3a(ii), the
APD90 rate response in the GPB model does not present the ﬁrst fast phase
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Figure 4. Biomarkers of arrhythmic risk from TP06, GPB and CRLP models: (a) steady-state
AP for CL= 1000ms; (b) steady-state [Ca2+]i transient for CL= 1000ms; (c) APD90 rate
adaptation to abrupt changes in CL (from 1000ms to 600ms); (d) S1S2 restitution curve; (e)
dynamic restitution curve; (f ) normalized [Ca2+]i rate dependence; and (g) normalized [Na+]i
rate dependence. (f,g) Normalization is performed with respect to the lowest tested frequency, i.e.
0.25Hz. Red dashed line, GPB; green full line, CRLP; blue dashed-dotted line, TP06. (Online
version in colour.)
(ﬁgure 4c). For the S1S2 restitution curves (ﬁgure 4d), the TP06 model is in
better agreement with the experimental data of earlier studies [38,42] than the
GPB model.
For the CRLP model, seven out of 12 analysed biomarkers are within
physiological range and the other three are closer to the physiological range
when compared with the GPB and the TP06 models. As for systolic and diastolic
[Ca2+]i levels at 1Hz, TP06 outperforms CRLP. A signiﬁcant change in the shape
of the S1S2 restitution curve is observed for the CRLP model when compared
with the GPB model (ﬁgure 4d). The behaviour shown by the CRLP model is in
agreement with the experimental data [38].
(iv)Potassium current blocks
Table 4 summarizes the effect of potassium current blocks on epicardial APs
computed using the three tested models. Results are given as percentage of
variation of the APD90 value with respect to control conditions. In those cases
where more than one current was blocked, the variation refers to the APD90 value
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Figure 5. Effect of blocking potassium currents for the GPB and CRLP models. (a) Effect
of completely blocking IKr and IKs currents in the GPB model (black solid line, control; red
dotted line, IKr block; blue dashed line, IKs block; green dashed-dotted line; IKr and IKs block).
(b) Effect of completely blocking IKr and partially blocking IK1 in the GPB model (black solid line,
control; red dotted line, IKr block; blue dashed line, IK1 block; green dashed-dotted line; IKr and
IK1 block). (c) Effect of completely blocking IKr and IKs currents in the CRLP model (black solid
line, control; red dotted line, IKr block; blue dashed line, IKs block; green dashed-dotted line; IKr
and IKs block). (d) Effect of completely blocking IKr and partially blocking IK1 in the CRLP model
(black solid line, control; red dotted line, IKr block; blue dashed line, IK1 block; green dashed-dotted
line; IKr and IK1 block). (Online version in colour.)
Table 4. Percentages of variation in APD90 caused by blocking different potassium currents. Normal
font indicates within physiological range. Bold font indicates out of physiological range but better
than previous models. Italic font indicates out of physiological range.
current reference TP06 GPB CRLP experiments
IKs 0% control 74.9 0.7 0.6 <2.8
IKr 0% control 15.9 18.6 14.1 44± 4
IKr 0% IKr block — 1.4 0.8 9
IKs 0%
IK1 50% control 3.6 11.5 14.6 4.8± 1.5
IKr 0% IKr block 8.9 15.6 21.1 33
IK1 50%
obtained when only the ﬁrst current was blocked. Experimental values are taken
from the study of Jost et al. [44]. It is clear from table 4 that the GPB model
performs better than the TP06 model regarding current blocks. The CRLP model
performs similar to the GPB model. Figure 5 illustrates the effect of current
blocks on the AP shape for the GPB and CRLP models.
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Figure 6. (a) CV and (b) APD90 restitution curves for the TP06, GPB and CRLP models in a
simulated one-dimensional ﬁbre. Blue dashed-dotted line, TP06; green solid line, CRLP; red dashed
line, GPB. (Online version in colour.)
(v)Restitution in ﬁbre
Figure 6 shows CV and APD90 restitution curves computed by applying the
S1S2 protocol to the simulated one-dimensional ﬁbre. Regarding CV restitution,
the three models present similar behaviours, with only notable differences (greater
than 5 cm s−1) observed between the TP06 model and the other two models
(GPB and CRLP) in the ﬁnal part of the curve, i.e. for DI values above
200ms. Regarding APD90 restitution, both the TP06 and CRLP models present
steep restitution curves, with high slope (close to 1) only for a narrow DI
interval in the case of the CRLP model and for a much wider DI range in
the case of the TP06 model (with slope values above 1). The GPB model
shows a relatively ﬂat APD90 restitution curve. Those results are in good
correspondence with the observations from restitution curves measured in isolated
cells (ﬁgure 4d).
(b) Results for hyperkalaemic conditions
(i)Action potential properties
Figure 7a,c shows a comparison of the AP shape computed in a single cell
and tissue for different levels of [K+]o using the CRLP model. Figure 7b,d shows
the effect of varying [K+]o on the resting potential in a single cell and tissue.
As expected, hyperkalaemia shortens the APD90 and leads to elevated resting
potential, in both single cells and tissue.
From ﬁgure 7c, it is also clear that, for high [K+]o levels, the AP shape varies
between even and odd beats, thus leading to the occurrence of AP alternans.
Further analysis on the alternating AP behaviour and the [K+]o threshold for its
occurrence can be found in §3b(iii).
(ii)Conduction velocity
Figure 8a shows CV as a function of [K+]o computed from the simulated one-
dimensional ﬁbre using the CRLP model. As expected, hyperkalaemia leads to
a decrease in CV. However, ‘supernormal conduction’ is not observed for [K+]o
levels below physiological values (5.4mM) as has been observed in other studies
[45,46]. Our results also show that conduction block occurs for [K+]o > 10.4.
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Figure 7. Simulated hyperkalaemia in (a,b) isolated cells and (c,d) one-dimensional ﬁbre
tissue using the CRLP model: (a) AP shape for varying [K+]o (dark blue, 4; green, 6; red,
8; light blue, 10) in isolated cells; (b) resting potential for varying [K+]o in isolated cells; (c)
AP shape for varying [K+]o (dark blue, 4; green, 6; red, 8; light blue, 10) in one-dimensional
ﬁbre; and (d) resting potential for varying [K+]o in one-dimensional ﬁbre. (Online version
in colour.)
(iii)Action potential duration and effective refractory period
Figure 8b shows ERP and APD90 of the last basic (S1) beat for different
[K+]o values computed in the simulated one-dimensional ﬁbre using the CRLP
model. Results show that hyperkalaemia causes post-repolarization refractoriness.
The difference between ERP and APD90 remains almost constant for [K+]o ≤
6mM, with this difference increasing rapidly for [K+]o > 6mM. For [K+]o >
9.8mM, alternans appear in the tissue, causing the ERP and APD90 curves
to branch out (ﬁgure 8b). This characteristic of the ERP and APD90 curves
has not been reported in other human ventricular simulation studies of
the literature, but is in agreement with the experimental results in other
species and with clinical data [47–49]. We tested the same hyperkalaemic
conditions in simulated TP06 and GPB one-dimensional ﬁbres and we could
not observe branching out of the ERP or APD90 curves after increasing [K+]o
up to 15mM.
Figure 8c depicts AP propagation in the simulated CRLP one-dimensional
ﬁbre for [K+]o = 10mM. Alternans were observed for all computed positions
within the ﬁbre. Figure 8d shows ICaL, INa and [Ca2+]i, each normalized to its
maximum value, for the same time period shown in ﬁgure 8c. Results indicate
that conduction relies on INa even for the highly depressed APs. For the long
APs, the AP upstroke is divided into two components, the ﬁrst one characterized
by a steep upstroke and supported by INa, and the second one supported by ICaL,
in agreement with the results reported in [50].
Phil. Trans. R. Soc. A (2011)
 on February 12, 2017http://rsta.royalsocietypublishing.org/Downloaded from 
4226 J. Carro et al.
4 6 8 10
20
40
60
80
4 6 8 10
0
500
1000
ER
P,
 A
PD
90
 
(m
s)
6000 6500 7000 7500 8000 8500
−100
−50
0
50
time (ms)
6000 6500 7000 7500 8000 8500
time (ms)
−1
0
1
V m
 
(m
V)
[K+]o (mM) [K+]o (mM)
CV
 (c
m 
s–
1 )
(a)
(c)
(b)
(d)
Figure 8. Behaviour of the CRLP model under hyperkalaemic conditions in a one-dimensional ﬁbre:
(a) CV versus [K+]o; (b) dependence of ERP (blue line with ﬁlled triangles) and APD90 (green
line with ﬁlled circles) with [K+]o; (c) example of alternans for [K+]o = 10.0mM, each colour
representing a different position in the ﬁbre; and (d) value of different currents normalized to the
maximal value of each one in the same example as the previous results (blue full line, ICaL; red
dashed line, INa; green dashed-dotted line, [Ca+2]i). (Online version in colour.)
4. Discussion and conclusions
In this study, a new human ventricular cell model, the CRLP model,
was developed based on the recently proposed GPB model. The CRLP
model combines recent experimental measurements of potassium currents,
and reformulates the L-type calcium current by introducing fast and slow
voltage-dependent inactivation gates, similar to the formulation proposed in the
TP06 model. That new formulation led to ICaL dynamics that were in good
agreement with experimental data and, more notably, allowed the CRLP model to
accurately reproduce S1S2 restitution and APD90 rate adaptation characteristics.
All the modiﬁcations were made with the aim of maintaining the advantages
that the GPB model has over previous models, such as the TP06 model, while
improving the performance on other electrophysiological aspects. The novelty of
this study was that model development was not only based on the incorporation
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of new data from experiments on individual ionic currents or concentrations.
More importantly, the development was driven by analysing the ability of the
model to replicate a set of well-established arrhythmic risk biomarkers, and on a
sensitivity analysis of those biomarkers to variations in model parameters. The
proposed model development framework allows model performance to be assessed
under a variety of conditions, either physiological or pathological. This provides
useful information for the adjustment of different model parameters that do not
directly depend on individual current measurements or concentrations, and which
would otherwise be set in an ad hoc manner.
(a)Modiﬁcations
The introduction of fast and slow ICaL inactivation gates in the CRLP model
led to a more physiological APD90 rate adaptation response to abrupt changes
in CL when compared with the GPB model. However, by doing so, a larger
ICaL current was obtained for the CRLP model, which led to the reformulation
of IK1 and readjustments of other parameters in order to keep APD90 within
physiological values. The resulting APD90 value for the CRLP model was closer
to the APD90 value of the TP06 model, without signiﬁcantly altering the AP
triangulation of the GPB model, which was well within the reported physiological
range. The other modiﬁcations introduced into the CRLP model rendered most
of the investigated biomarkers to be within the physiological range or otherwise
closer to the physiological range when compared with the GPB and the TP06
models. In this regard, it was only for systolic and diastolic [Ca2+]i levels at 1Hz
that TP06 outperformed CRLP. In addition, the CRLP model showed improved
performance with respect to the GPB model regarding the S1S2 restitution, not
only by bringing the maximum S1S2 restitution slope within the physiological
range, but also by providing a shape for the restitution curve in good agreement
with the experimental measurements [38].
Even though the modiﬁcations signiﬁcantly improved the performance of the
CRLP model over the GPB model in reproducing experimental data related
to a number of arrhythmic risk biomarkers, they have minimally affected the
behaviour of the model against potassium current blocks. In this regard, the
CRLP model still provides results in very good agreement with the available
experimental data regarding AP response to IKr, IKs and IK1 blocks [44].
(b) Simulation of hyperkalaemic conditions
Simulations under hyperkalaemic conditions showed that APD90 progressively
decreased with the level of [K+]o, whereas ERP increased after a threshold
was reached ([K+]o ≈ 6mM) in [K+]o. CV decreased with hyperkalaemia and
conduction was blocked above [K+]o = 10.4mM. These results suggest that the
longer ERP values and the occurrence of conduction block above [K+]o = 10.4mM
in the central zone of acute ischaemic tissue could cause areas of conduction block
that could set a substrate for reentrant arrhythmias. Additionally, alternans were
observed in ERP and APD90 for [K+]o > 9.8mM. These results are in agreement
with experimental studies, where alternans were observed in the cells of the heart’s
ischaemic zone [47,48]. To the authors’ knowledge, this is the ﬁrst time that
those observations have been reported using a human ventricular AP model.
That type of behaviour was not observed in either the TP06 or the GPB models.
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For the TP06 model, conduction block occurred for [K+]o ≈ 15mM without the
occurrence of alternans [51]. For the GPB model, conduction block occurred for
[K+]o ≈ 9mM and alternans were not observed either.
(c) Data sources
As described in the study of Niederer et al. [3], one of the problems
on reutilization of model components in electrophysiology is the inclusion of
components adjusted with data from different species. For that reason, in this
work all the modiﬁcations were made by using model components formulated
based on human data only [1] or by ﬁtting equations to additional human data
available from the literature [9]. We did not try modifying other ionic currents
or concentrations for which human data were not available. Regarding the types
of human data used in the study, they all corresponded to adult humans, except
for the data taken from the study by Pelzmann et al. [15], in which ICaL was
measured in children. Those data were used because the study clearly showed that
there were not signiﬁcant differences in the ICaL current characteristics measured
in children when compared with adults.
(d)Model limitations
The developed CRLP model has a number of limitations, some of them
inherited from the GPB model on which it was based, and others independent
of it. Phase 1 of the AP shows an atypical behaviour. We believe this behaviour
is caused by the Ito current. However, we have not attempted to modify this
current mainly because new human data were not available for that purpose. This
current happens to be the only one whose deﬁnition differentiates endocardial
and epicardial cells in the GPB model and in the CRLP model as well. A second
limitation of the CRLP model, which is also a limitation of the GPB model, is
that a description is not provided for the electrophysiology of mid-myocardial
cells. Another limitation of the CRLP model has to do with calcium deﬁnition.
The results of the analysis conducted in this study point out the importance that
the ICaL current as well as the [Ca2+]i dynamics have over different arrhythmic
risk biomarkers. Many studies have attempted to provide accurate deﬁnitions of
[Ca2+]i dynamics in human ventricular cells, but this is still an area of intensive
research. The present study suggests the need to continue with the development of
more reliable calcium dynamics models that allow the performance of whole-cell
AP models to be improved.
On top of the above-described limitations, a comment is in order regarding
the comparison of human ventricular AP models. It is clear that each model
has been developed to reproduce certain electrophysiological behaviours observed
from experimental recordings. Also, considering the huge variability in the
experimental data, model comparison becomes a challenging task for which
a model should never be qualiﬁed as being an improvement over another one just
because it is able to reproduce speciﬁc experimental observations that the other
model is not able to. In this study, we used the term ‘improvement’ exclusively
to refer to the fact that, considering the set of investigated arrhythmic risk
biomarkers, the CRLP model provides a response that is more in line with the
averaged experimental data used for evaluation purposes.
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(e) Future work
Although the results of this study showed the value of the proposed framework
for the development of ionic models, further research is needed to investigate
how arrhythmic risk biomarkers are modulated by the interaction of different
model parameters when those parameters vary simultaneously. In this regard,
an analysis of variance of the studied biomarkers can provide additional useful
information for adjusting independent parameters in order to bring a given
biomarker into the physiological range without greatly affecting other biomarkers
in the process. Future developments of the model will continue in this direction, as
well as in adapting the model for simulating ischaemia through the incorporation
of ATP-sensitive potassium channels (IKATP). Simulations with the CRLP model
will be conducted not only in a one-dimensional ﬁbre, but in two-dimensional
tissue and in a realistic human ventricular geometry.
This study was ﬁnancially supported by grants TEC2010-19410 and TEC2010-21703-C03-02 from
Ministerio de Ciencia e Innovación, Spain, PI 144/2009 and Grupo Consolidado T30 from Gobierno
de Aragón, Spain, an International Joint Project from the Royal Society, UK, and fellowship
B040/2010 from Gobierno de Aragón, Spain. The authors would like to thank Eleonora Grandi for
sharing the codes of the GPB model before making them available at the CellML repository.
References
1 ten Tusscher, K. & Panﬁlov, A. 2006 Alternans and spiral breakup in a human ventricular
tissue model. Am. J. Physiol. Heart Circ. Physiol. 291, H1088–H1100. (doi:10.1152/ajpheart.
00109.2006)
2 ten Tusscher, K., Noble, D., Noble, P. J. & Panﬁlov, A. 2004 A model for human ventricular
tissue. Am. J. Physiol. Heart Circ. Physiol. 286, H1573–H1589. (doi:10.1152/ajpheart.00794.
2003)
3 Niederer, S., Fink, M., Noble, D. & Smith, N. 2009 A meta-analysis of cardiac electrophysiology
computational models. Exp. Physiol. 94, 486–495. (doi:10.1113/expphysiol.2008.044610)
4 Romero, L., Pueyo, E., Fink, M. & Rodríguez, B. 2009 Impact of ionic current variability on
human ventricular cellular electrophysiology. Am. J. Physiol. Heart Circ. Physiol. 297, H1436–
H1445. (doi:10.1152/ajpheart.00263.2009)
5 Iyer, V., Mazhari, R. & Winslow, R. 2004 Computational model of the human left ventricular
epicardial myocyte. Biophys. J. 87, 1507–1525. (doi:10.1529/biophysj.104.043299)
6 Bueno-Orovio, A., Cherry, E. M. & Fenton, F. H. 2008 Minimal model for human ventricular
action potentials in tissue. J. Theor. Biol. 253, 544–560. (doi:10.1016/j.jtbi.2008.03.029)
7 Grandi, E., Pasqualini, F. S. & Bers, D. M. 2010 A novel computational model of the human
ventricular action potential and Ca transient. J. Mol. Cell. Cardiol. 48, 112–121. (doi:10.1016/
j.yjmcc.2009.09.019)
8 Shannon, T. R., Wang, F., Puglisi, J., Weber, C. & Bers, D. M. 2004 A mathematical
treatment of integrated Ca dynamics within the ventricular myocyte. Biophys. J. 87, 3351–3371.
(doi:10.1529/biophysj.104.047449)
9 Fink, M., Noble, D., Virag, L., Varro, A. & Giles, W. R. 2008 Contributions of HERG K+
current to repolarization of the human ventricular action potential. Prog. Biophys. Mol. Biol.
96, 357–376. (doi:10.1016/j.pbiomolbio.2007.07.011)
10 Beuckelmann, D. J., Näbauer, M. & Erdmann, E. 1991 Characteristics of calcium-current in
isolated human ventricular myocytes from patients with terminal heart failure. J. Mol. Cell.
Cardiol. 23, 929–937. (doi:10.1016/0022-2828(91)90135-9)
11 Benitah, J., Bailly, P., D’Agrosa, M., Da Ponte, J., Delgado, C. & Lorente, P. 1992 Slow
inward current in single cells isolated from adult human ventricles. Pﬂügers Arch. 421, 176–187.
(doi:10.1007/BF00374825)
Phil. Trans. R. Soc. A (2011)
 on February 12, 2017http://rsta.royalsocietypublishing.org/Downloaded from 
4230 J. Carro et al.
12 Mewes, T. & Ravens, U. 1994 L-type calcium currents of human myocytes from ventricle
of non-failing hearts and atrium. J. Mol. Cell. Cardiol. 26, 1307–1320. (doi:10.1006/jmcc.
1994.1149)
13 Sun, H., Leblanc, N. & Nattel, S. 1997 Mechanisms of inactivation of L-type calcium channels
in human atrial myocytes. Am. J. Physiol. Heart Circ. Physiol. 272, H1625–H1635.
14 Li, G. R., Yang, B., Feng, J., Bosch, R. F., Carrier, M. & Nattel, S. 1999 Transmembrane
ICa contributes to rate-dependent changes of action potentials in human ventricular myocytes.
Am. J. Physiol. Heart Circ. Physiol. 276, H98–H106.
15 Pelzmann, B., Schaffer, P., Bernhart, E., Lang, P., Machler, H., Rigler, B. & Koidl, B.
1998 L-type calcium current in human ventricular myocytes at a physiological temperature
from children with tetralogy of Fallot. Cardiovasc. Res. 38, 424–432. (doi:10.1016/S0008-6363
(98)00002-9)
16 Magyar, J. et al. 2000 Effects of endothelin-1 on calcium and potassium currents in undiseased
human ventricular myocytes. Pﬂügers Arch. 441, 144–149. (doi:10.1007/s004240000400)
17 Drouin, E., Charpentier, F., Gauthier, C., Laurent, K. & Marec, H. L. 1995 Electrophysiologic
characteristics of cells spanning the left ventricular wall of human heart: evidence for presence
of M cells. J. Am. Coll. Cardiol. 26, 185–192. (doi:10.1016/0735-1097(95)00167-X)
18 Hodgkin, A. L. & Huxley, A. F. 1952 A quantitative description of ion currents and its
applications to conduction and excitation in nerve membranes. J. Physiol. 117, 500–544.
19 Keener, J. & Sneyd, J. 1998 Mathematical physiology. Berlin, Germany: Springer.
20 Heidenreich, E., Ferrero, J. M., Doblaré, M. & Rodríguez, J. F. 2010 Adaptive macro ﬁnite
elements for the numerical solution of monodomain equations in cardiac electrophysiology.
Ann. Biomed. Eng. 38, 2331–2345. (doi:10.1007/s10439-010-9997-2)
21 Taggart, P., Sutton, P., Opthof, T., Coronel, R., Trimlett, R. & Pugsley, W. 2000
Inhomogeneous transmural conduction during early ischemia in patients with coronary artery
disease. J. Mol. Cell. Cardiol. 32, 621–639. (doi:10.1006/jmcc.2000.1105)
22 Rush, S. & Larsen, H. 1978 A practical algorithm for solving dynamic membrane equations.
IEEE Trans. Biomed. Eng. 25, 389–392. (doi:10.1109/TBME.1978.326270)
23 Hondeghem, L., Carlsson, L. & Duker, G. 2001 Instability and triangulation of the action
potential predict serious proarrhythmia, but action potential duration prolongation is
antiarrhythmic. Circulation 103, 2004–2013. (doi:10.1161/01.CIR.103.15.2004)
24 Volders, P., Vos, M., Szabo, B., Sipido, K., de Groot, S., Gorgels, A., Wellens, H. & Lazzara, R.
2000 Progress in the understanding of cardiac early afterdepolarizations and torsades de pointes:
time to revise current concepts. Cardiovasc. Res. 46, 376–392. (doi:10.1016/S0008-6363(00)
00022-5)
25 Pieske, B., Maier, L., Bers, D. & Hasenfuss, G. 1999 Ca2+ handling and sarcoplasmic
reticulum Ca2+ content in isolated failing and nonfailing human myocardium. Circ. Res. 85,
38–46.
26 Bers, D. M. & Despa, S. 2006 Cardiac myocytes Ca2+ and Na+ regulation in normal and failing
hearts. J. Pharmacol. Sci. 100, 315–322. (doi:10.1254/jphs.CPJ06001X)
27 Pueyo, E., Smetana, P., Caminal, P., de Luna, A., Malik, M. & Laguna, P. 2004 Characterization
of QT interval adaptation to RR interval changes and its use as a risk-stratiﬁer of arrhythmic
mortality in amiodarone-treated survivors of acute myocardial infarction. IEEE Trans. Biomed.
Eng. 51, 1511–1520. (doi:10.1109/TBME.2004.828050)
28 Pueyo, E., Husti, Z., Hornyik, T., Baczkó, I., Laguna, P., Varró, A. & Rodríguez, B. 2010
Mechanisms of ventricular rate adaptation as a predictor of arrhythmic risk. Am. J. Physiol.
Heart Circ. Physiol. 298, H1577–H1587. (doi:10.1152/ajpheart.00936.2009)
29 Nolasco, J. & Dahlen, R. 1968 A graphic method for the study of alternation in cardiac action
potentials. J. Appl. Physiol. 25, 191–196.
30 Weiss, J., Karma, A., Shiferaw, U., Chen, P., Garﬁnkel, A. & Qu, Z. 2006 From pulses to
pulseless: the saga of cardiac alternans. Circ. Res. 98, 1244–1253. (doi:10.1161/01.RES.0000
224540.97431.f0)
31 Levi, A. et al. 1997 Role of intracellular sodium overload in the genesis of cardiac arrhythmias.
J. Cardiovasc. Electrophysiol. 8, 700–721. (doi:10.1111/j.1540-8167.1997.tb01834.x)
Phil. Trans. R. Soc. A (2011)
 on February 12, 2017http://rsta.royalsocietypublishing.org/Downloaded from 
A human ventricular cell model 4231
32 Murphy, E. & Eisner, D. 2009 Regulation of intracellular and mitochondiral sodium in health
and disease. Circ. Res. 104, 292–303. (doi:10.1161/CIRCRESAHA.108.189050)
33 Fülöp, L., Bányász, T., Magyar, J., Szentandrássy, N., Varró, A. & Nánási, P. P. 2004
Reopening of L-type calcium channels in human ventricular myocytes during applied
epicardial action potentials. Acta Physiol. Scand. 180, 37–94. (doi:10.1046/j.0001-6772.2003.
01223.x)
34 Iost, N., Virág, L., Opincariu, M., Szécsi, J., Varró, A. & Papp, J. G. 1998 Delayed rectiﬁer
potassium current in undiseased human ventricular myocytes. Cardiovasc. Res. 40, 508–515.
(doi:10.1016/S0008-6363(98)00204-1)
35 Szentadrassy, N. et al. 2005 Apico-basal inhomogeneity in distribution of ion channels in canine
and human ventricular myocardium. Cardiovasc. Res. 65, 851–860. (doi:10.1016/j.cardiores.
2004.11.022)
36 Verkerk, A. O., Wilders, R., Veldkamp, M. W., de Geringel, W., Kirkels, J. H. & Tan, H.
L. 2005 Gender disparities in cardiac cellular electrophysiology and arrhythmia susceptibility
in human failing ventricular myocytes. Int. Heart J. 46, 1105–1118. (doi:10.1536/ihj.46.
1105)
37 Virág, L., Iost, N., Opincariu, M., Szolnoky, J., Szécsi, J., Bogáts, G., Szenohradszky, P.,
Varró, A. & Papp, J. 2001 The slow component of the delayed rectiﬁer potassium current
in undiseased human ventricular myocytes. Cardiovasc. Res. 49, 790–797. (doi:10.1016/S0008-
6363(00)00306-0)
38 Franz, M. R., Swerdlow, C. D., Liem, L. B. & Schaefer, J. 1988 Cycle length dependence
of human action potential duration in vivo. Effects of single extrastimuli, sudden sustained
rate acceleration and deceleration, and different steady-state frequencies. J. Clin. Invest. 82,
972–979. (doi:10.1172/JCI113706)
39 Li, G. R., Feng, J., Yue, L. & Carrier, M. 1998 Transmural heterogeneity of action potentials
and Ito1 in myocytes isolated from the human right ventricle. Am. J. Physiol. Heart Circ.
Physiol. 275, H369–H377.
40 Beuckelmann, D. J., Nabauer, M. & Erdmann, E. 1992 Intracellular calcium handling in
isolated ventricular myocytes from patients with terminal heart failure. Circulation 85,
1046–1055.
41 Schmidt, U., Hajjar, R., Helm, P., Kim, C., Doye, A. & Gwathmey, J. 1998 Contribution
of abnormal sarcoplasmic reticulum ATPase activity to systolic and diastolic dysfunction
in human heart failure. J. Mol. Cell. Cardiol. 30, 1929–1937. (doi:10.1006/jmcc.1998.
0748)
42 Nash, M., Gradley, C., Sutto, P., Clayton, R., Kallis, P., Hayward, M., Paterson, D. &
Taggart, P. 2006 Whole heart action potential duration restitution properties in cardiac
patients: a combined clinical and modelling study. Exp. Physiol. 91, 339–354. (doi:10.1113/
expphysiol.2005.031070)
43 Pieske, B., Maier, L., Piacentino III, V., Weisser, J., Hasenfuss, G. & Houser, S. 2002 Rate
dependence of [Na+]i and contractility in nonfailing and failing human myocardium. Circulation
106, 447–453. (doi:10.1161/01.CIR.0000023042.50192.F4)
44 Jost, N. et al. 2008 Molecular basis of repolarization reserve differences between dogs and man.
Circulation 118(Meeting Abstr. Suppl.), S342.
45 Shaw, R. M. & Rudy, Y. 1997 Electrophysiologic effects of acute myocardial ischemia: a
mechanistic investigation of action potential conduction and conduction failure. Circ. Res. 80,
124–138.
46 Kagiyama, Y., Hill, J. & Gettes, L. 1982 Interaction of acidosis and increased extracellular
potassium on action potential characteristic and conduction in guinea pig ventricular muscle.
Circ. Res. 51, 614–623.
47 Dilly, S. G. & Lab, M. J. 1988 Electrophysiological alternans and restitution during acute
regional ischaemia in myocardium of anaesthetized pig. J. Physiol. 402, 315–333.
48 Kurz, R. W., Mohabir, R., Ren, X. L. & Franz, M. R. 1993 Ischaemia induced alternans of
action potential duration in the intact-heart: dependence on coronary ﬂow, preload and cycle
length. Eur. Heart J. 14, 1410–1420. (doi:10.1093/eurheartj/14.10.1410)
Phil. Trans. R. Soc. A (2011)
 on February 12, 2017http://rsta.royalsocietypublishing.org/Downloaded from 
4232 J. Carro et al.
49 Martínez, J. P., Olmos, S., Wagner, G. & Laguna, P. 2006 Characterization of repolarization
alternans during ischemia: time-course and spatial analysis. IEEE Trans. Biomed. Eng. 53,
701–711. (doi:10.1109/TBME.2006.870233)
50 Ferrero, J. M., Trenor, B., Rodriguez, B. & Saiz, J. 2003 Electrical activity and reentry
during acute regional myocardial ischemia: insights from simulations. Int. J. Bifurc. Chaos
13, 3703–3715. (doi:10.1142/S0218127403008806)
51 Rodriguez, J., Heidenreich, E., Romero, L., Ferrero, J. & Doblare, M. 2008 Post-repolarization
refractoriness in human ventricular cardiac cells. In Computers in cardiology 2008, Bologna,
Italy, 14–17 September, vol. 35, pp. 581–584. Washington, DC: IEEE Computer Society Press.
See http://www.cinc.org/archives/2008/pdf/0581.pdf.
Phil. Trans. R. Soc. A (2011)
 on February 12, 2017http://rsta.royalsocietypublishing.org/Downloaded from 
